Larvol Delta - AmMax-Bio-and-MD-Anderson-Announce-Agreements-to-Advance-Development-of-AMB066-in-Colorectal-Cancer-Patients-with-Minimal-Residual-Disease

AMB-066 - AmMax

https://www.globenewswire.com/news-release/2024/12/10/2994508/0/en/AmMax-Bio-and-MD-Anderson-Announce-Agreements-to-Advance-Development-of-AMB-066-in-Colorectal-Cancer-Patients-with-Minimal-Residual-Disease.html

Dec 10, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next